Five-Year Outcomes of Endovascular Aortic Repair With the TREO Abdominal Endograft

Abstract

Purpose:

Newer generation abdominal endografts, including Treo (Terumo Aortic, Sunrise, Florida), have shown optimal safety and effectiveness in treating abdominal aortic aneurysms (AAAs), even with hostile anatomy over the short- and mid-term. The durability of such results, however, is still a controversial issue, due to the paucity of long-term data. Our aim is to show the long-term outcomes of endovascular aortic repair of both standard and hostile AAAs with the Treo endograft on a cohort of patients treated between 2016 and 2017.

Methods:

We analyzed the postoperative follow-up of 37 consecutive patients who have undergone endovascular aortic repair (EVAR) with the Treo Endograft between 2016 and 2017, whose baseline clinical conditions, operative data, and short-term outcomes had been published in 2018. All patients were followed up by computed tomography angiography (CTA) at 6 and 12 months and 5 years postoperatively. Primary endpoints were aortic-related mortality, type I–III endoleak (EL), and reintervention rate. Secondary endpoints were the rates of type II ELs and aneurysm sac regression.

Results:

Of 37 patients, 27 had at least one criterion of anatomic hostility and 11 were performed outside the device-specific instructions for use (IFU). In the perioperative period, we observed 100% technical success, with no perioperative mortality. Over a mean follow-up of 5.5 years (66 months), 3 patients (8.1%) were lost to follow-up and 3 (8.1%) died of non-aortic causes (overall survival: 91.9%). One type IA EL of an AAA with a hostile neck (but within the IFU) and a type III EL of an AAA with standard anatomy were observed and treated by endovascular relining (overall reintervention rate: 5.5%). Four type II ELs were associated with aneurysm sac stability over time and are still under surveillance. Mean aneurysm shrinkage was 11.25±8.30 mm.

Conclusion:

The optimal results of the Treo Endograft in terms of complication and reintervention rates reported over the mid-term by the current literature (ITA-ENDOBOOT registry) are maintained on the long term, both in case of hostile and friendly aortic anatomy, with a satisfactory shrinkage rate of the aneurysm sac.

Clinical Impact

The innovative characteristics of Treo and its short-term results are well-known and reported. The present case series contributes to the scientific validation of a new-generation abdominal aortic endograft over the long-term, focusing especially on its performance in treating AAAs with hostile anatomy. Its 5-years outcomes confirm the optimal results already reported over the short- and mid-term.

Keywords

TREO abdominal aortic aneurysm endoleak endovascular aneurysm repair stent graft

Get full access to this article

View all access options for this article.

References

Powell

Sweeting

Ulug

, et al; EVAR-1, DREAM, OVER and ACE Trialists. Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. Br J Surg. 2017;104(3):166–178.

Georgakarakos

Kratimenos

Koutsoumpelis

, et al. The Bolton Treo endograft for treatment of abdominal aortic aneurysms: just another trimodular platform? Expert Rev Med Devices. 2018;15(1):5–14. doi:10.1080/17434440.2018.1419864.

Bernardini

Litterscheid

Torsello

, et al. A meta-analysis of safety and efficacy of endovascular aneurysm repair in aneurysm patients with severe angulated infrarenal neck. PLoS ONE. 2022;17(2):e0264327. doi:10.1371/journal.pone.0264327.

Marone

Rinaldi

Lovotti

, et al. The Bolton Treo endograft: a single-center preliminary experience. Ann Vasc Surg. 2019;56:139–146. doi:10.1016/j.avsg.2018.08.080.

Marone

Freyrie

Ruotolo

, et al. Expert opinion on hostile neck definition in endovascular treatment of abdominal aortic aneurysms (a Delphi consensus). Ann Vasc Surg. 2020;62:173–182. doi:10.1016/j.avsg.2019.05.049.

Georgakarakos

Karaolanis

Argyriou

, et al. Update on the TREO endograft device: overview of its safety and efficacy. Expert Rev Med Devices. 2022;19(1):31–35. doi:10.1080/17434440.2022.2020093.

Boitano

Eagleton

MJ.

The TREO abdominal aortic stent-graft system. Future Cardiol. 2021;17(5):805–810. doi:10.2217/fca-2020-0158.

Eagleton

Stoner

Henretta

, et al; TREO Investigators. Safety and effectiveness of the TREO stent graft for the endovascular treatment of abdominal aortic aneurysms. J Vasc Surg. 2021;74(1):114–123.e3.

Reina

Galzerano

Diliberti

, et al. Midterm outcomes of 71 consecutive abdominal aortic aneurysm patients treated with the TREO stent-graft in a single center. Int Angiol. 2020;39(5):405–410.

10.

Uberoi

Setacci

Lescan

, et al; RATIONALE Investigators Global post-market clinical follow-up of the treovance stent-graft for endovascular aneurysm repair: one-year results from the RATIONALE registry. J Endovasc Ther. 2018;25(6):726–734.

11.

D’Oria

Galeazzi

Veraldi

, et al; ITA-ENDOBOOT registry collaborators. Impact of proximal neck anatomy on short-term and mid-term outcomes after treatment of abdominal aortic aneurysms with new-generation low-profile endografts. Results from the multicentric “ITAlian North-East Registry of ENDOvascular Aortic Repair With the BOltOn Treo Endograft (ITA-ENDOBOOT).” Ann Vasc Surg. 2022;80:37–49. doi:10.1016/j.avsg.2021.08.059.

12.

Sirignano

Ceruti

Aloisi

, et al. Is EVAR feasible in challenging aortic neck anatomies? a technical review and ethical discussion. J Clin Med. 2022;11(15):4460. doi:10.3390/jcm11154460.

13.

Barleben

Mathlouthi

Mehta

, et al. Ovation trial investigators. Long-term outcomes of the ovation stent graft system investigational device exemption trial for endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2020;72(5):1667–1673.e1. doi:10.1016/j.jvs.2020.01.066.

14.

Balceniuk

Zhao

Terbush

, et al. TREO aortic endograft demonstrates significant aneurysmal sac shrinkage. J Surg Res. 2019;241:48–52. doi:10.1016/j.jss.2019.03.048.